Suchergebnisse - "Morine, Yuji"

PubPharm (8)

1

Effect of Adjuvant Gemcitabine Combined with Low-dose 5-Fluorouracil and Cisplatin Chemotherapy for Advanced Biliary Carcinoma

enthalten in: Anticancer research | 2017

von Morine, Y. | Shimada, M. | Ikemoto, T. | +5

2

Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells

enthalten in: International journal of clinical oncology | 2011

von Iwahashi, S. | Shimada, M. | Utsunomiya, T. | +7

3

Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine : a special reference to gene-expression microarray analysis

enthalten in: Oncology reports | 2011

von Iwahashi, S. | Shimada, M. | Utsunomiya, T. | +6

4

Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells

enthalten in: International journal of clinical oncology | 2011

von Iwahashi, S. | Shimada, M. | Utsunomiya, T. | +7

5

Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells

enthalten in: International journal of clinical oncology | 2011

von Iwahashi, S. | Shimada, M. | Utsunomiya, T. | +7

6

Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells

enthalten in: International journal of clinical oncology | 2011

von Iwahashi, S. | Shimada, M. | Utsunomiya, T. | +7

7

Usefulness of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) in patients for unresectable biliary carcinoma

enthalten in: Hepato-gastroenterology | 2009

von Morine, Y. | Shimada, M. | Ikegami, T. | +6

8

Role of thymidine phosphorylase and orotate phosphoribosyltransferase mRNA expression and its ratio to dihydropyrimidine dehydrogenase in the prognosis and clinicopathological features of patients with pancreatic cancer

enthalten in: International journal of clinical oncology | 2007

von Miyake, K. | Imura, S. | Yoshizumi, T. | +3

1
[1]